Cable Hill Partners, LLC Ligand Pharmaceuticals Inc Transaction History

Cable Hill Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$107.38 - $129.34 $2,040 - $2,457	-19 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $633 - $823	-3 Reduced 13.64%	19 $5,000
Q1 2018 Apr 20, 2018	SELL	$138.63 - $182.62 $5,129 - $6,756	-37 Reduced 62.71%	22 $3,000
Q3 2017 Oct 27, 2017	SELL	$120.91 - $137.94 $241 - $275	-2 Reduced 3.28%	59 $8,000
Q2 2017 Aug 14, 2017	BUY	N/A	61	61 $7,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.